Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Strategic Asset Allocation Index
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Strategic Asset Allocation Index of 50.3% as of September 2023. Strategic assets (PP&E of CN¥3.01 Billion plus long-term investments of CN¥-) total CN¥3.01 Billion, measured against net assets of CN¥5.98 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Zhejiang Hisoar Pharmaceutical Co Ltd Strategic Asset Allocation Index (2003–2022)
This chart shows how Zhejiang Hisoar Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 20 annual periods from 2003 to 2022. As of September 2023, the index stands at 50.3%, representing strategic assets of CN¥3.01 Billion against net assets of CN¥5.98 Billion CNY. Explore Zhejiang Hisoar Pharmaceutical Co Ltd (002099) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2022, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 002099 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 50.7% | CN¥3.10 Billion | CN¥3.10 Billion | CN¥- | CN¥6.10 Billion | ▲ +2.0 pp |
| 2021 | 48.8% | CN¥2.98 Billion | CN¥2.98 Billion | CN¥- | CN¥6.11 Billion | ▲ +5.0 pp |
| 2020 | 43.8% | CN¥2.56 Billion | CN¥2.56 Billion | CN¥- | CN¥5.85 Billion | ▲ +2.7 pp |
| 2019 | 41.1% | CN¥2.35 Billion | CN¥2.29 Billion | CN¥67.88 Million | CN¥5.72 Billion | ▲ +4.8 pp |
| 2018 | 36.3% | CN¥1.96 Billion | CN¥1.89 Billion | CN¥67.89 Million | CN¥5.39 Billion | ▲ +6.0 pp |
| 2017 | 30.3% | CN¥1.56 Billion | CN¥1.48 Billion | CN¥81.09 Million | CN¥5.14 Billion | ▼ -1.4 pp |
| 2016 | 31.7% | CN¥1.51 Billion | CN¥1.31 Billion | CN¥201.05 Million | CN¥4.77 Billion | ▼ -12.0 pp |
| 2015 | 43.7% | CN¥1.56 Billion | CN¥1.54 Billion | CN¥24.31 Million | CN¥3.57 Billion | ▼ -2.7 pp |
| 2014 | 46.4% | CN¥1.47 Billion | CN¥1.47 Billion | CN¥- | CN¥3.18 Billion | ▼ -137.9 pp |
| 2013 | 184.2% | CN¥1.17 Billion | CN¥1.17 Billion | CN¥- | CN¥632.80 Million | ▲ +52.7 pp |
| 2012 | 131.5% | CN¥970.47 Million | CN¥970.47 Million | CN¥- | CN¥738.05 Million | ▲ +54.8 pp |
| 2011 | 76.7% | CN¥565.30 Million | CN¥565.30 Million | CN¥- | CN¥736.96 Million | ▲ +1.7 pp |
| 2010 | 75.0% | CN¥478.59 Million | CN¥478.59 Million | CN¥- | CN¥638.04 Million | ▲ +0.1 pp |
| 2009 | 74.9% | CN¥420.98 Million | CN¥420.98 Million | CN¥- | CN¥561.79 Million | ▼ -2.1 pp |
| 2008 | 77.1% | CN¥422.01 Million | CN¥422.01 Million | CN¥- | CN¥547.50 Million | ▲ +11.8 pp |
| 2007 | 65.3% | CN¥351.43 Million | CN¥351.43 Million | CN¥- | CN¥538.06 Million | ▲ +3.9 pp |
| 2006 | 61.4% | CN¥318.93 Million | CN¥318.93 Million | CN¥- | CN¥519.27 Million | ▼ -36.7 pp |
| 2005 | 98.1% | CN¥179.50 Million | CN¥179.50 Million | CN¥- | CN¥182.96 Million | ▼ -3.8 pp |
| 2004 | 101.9% | CN¥134.51 Million | CN¥134.51 Million | CN¥- | CN¥132.03 Million | ▼ -37.3 pp |
| 2003 | 139.2% | CN¥118.34 Million | CN¥118.34 Million | CN¥- | CN¥85.03 Million | — |